看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Pharmacokinetics of Pazufloxacin Me... 收藏
Pharmacokinetics of Pazufloxacin Mesilate Sodium Chloride in healthy Chinese volunteers after intravenous injection

Pharmacokinetics of Pazufloxacin Mesilate Sodium Chloride in healthy Chinese volunteers after intravenous injection

作     者:Wenjuan OuYang Yalan Zhang Pingsheng Xu Zhiyong Dai Hongying Ma Qun Qin 欧阳文鹃;张亚兰;徐平声;戴智勇;马虹英;秦群

作者机构:National Institution of Drug Clinical TrialXiangYa HospitalCentral South UniversityHunan410008China Department of PharmacyXiangYa HospitalCentral South UniversityHunan410008China 

基  金:the support of Laboratory of National Institution of Drug Clinical Trial Xiangya Hospital Central South University 

出 版 物:《Journal of Chinese Pharmaceutical Sciences》 (中国药学(英文版))

年 卷 期:2019年第28卷第1期

页      码:40-48页

摘      要:In the present study,we aimed to investigate the pharmacokinetics and dosage proportionality for a single,intravenous utilization of Pazufloxacin Mesilate Sodium Chloride,an injectable synthetic fluoroquinolone antibacterial agent,in healthy Chinese *** this open-labeled,three-dosage parallel study,subjects were randomized to receive a single dose of Pazufloxacin Mesilate at 150,300 or 600 mg(n=10,10 and 10,respectively)administered as a 30-min intravenous *** and urine samples were serially collected from 0 to 24 h after drug ***,the sample’s drug concentrations were analyzed via validated RP-HPLC *** receiving a single dose of Pazufloxacin Mesilate 150,300 or 600 mg were in accordance with the two compartment *** Cmax for each dosage group was 2.37±0.89,4.27±0.74 and 10.74±4.06 mg·mL(–1),respectively;and the AUC0→∞was 3.24±1.2,5.89±1.51 and 13.32±2.35 mg·h·mL–1,*** addition,Tmax for groups treated with 150,300 and 600 mg was 0.48±0.08,0.50±0.00 and 0.53±0.08 h,*** correlation analysis for AUC0→∞,Cmax and dosage suggested that pazufolxacin mesilate displayed dose proportion at the dose ranging from 150 to 600 *** data suggested that all three different dosage regimens fit with the two compartment ***,it presented a linear correlation between AUC0→∞,Cmax and dosage over the range of 150–600 mg.

主 题 词:Pazufloxacin Mesilate Accumulative urine excretion rate RP-HPLC Pharmacokinetics 

学科分类:1007[医学-药学类] 1006[医学-中西医结合类] 100706[100706] 100602[100602] 10[医学] 

核心收录:

D O I:10.5246/jcps.2019.01.005

馆 藏 号:203449050...

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分